** Inari Medical NARI.O shares down 3.4% at $94.49 on
light premarket volume as co looks to raise equity
** Seller of devices to remove blood clots commences 2 mln
share offering urn:newsml:reuters.com:*:nGNX20YJ8s
** BofA and Morgan Stanley joint lead bookrunners
** NARI has ~50.6 mln shares outstanding for roughly $5 bln
market cap, per Refinitiv data
** Shares have climbed 32% over the past month
** On Feb 23, co reported Q4 rev of $83 mln (up 71% yr/yr)
and forecasted FY 2022 rev of $350-$360 mln, reflecting approx
28% growth at the midpoint over 2021 urn:newsml:reuters.com:*:nGNX5R70cp
** Wall Street firmly bullish on NARI with avg rating of
"strong buy"; median PT is $105 - Refinitiv
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))